New research from The University of Queensland has found that women who have hot flushes and night sweats after menopause are 70 percent more likely to have heart attacks, angina and strokes.
School of Public Health Ph.D. student Dr. Dongshan Zhu has found women of any age who experience hot flushes and night sweats, also known as vasomotor symptoms or VMS, are more likely to experience non-fatal cardiovascular events.
“Until now, it’s been unclear if VMS is associated with cardiovascular disease, but now we know it to be true,” Dr. Zhu said.
“Further, VMS before menopause increases a woman’s chance of cardiovascular events by 40 percent.”
Dr. Zhu also found that the risk of cardiovascular events was more related to the severity of the hot flushes and night sweats rather than the frequency or duration.
“We found that women with severe VMS were more than twice as likely to experience a non-fatal cardiovascular event compared with women who had no symptoms,” he said.
Dr. Zhu used data from InterLACE, a major collaboration of 25 studies of more than 500,000 women around the world.
Senior author on the study Professor Gita Mishra said the findings may have important clinical implications.
“This research helps to identify women who are at a higher risk for the development of cardiovascular events and who may need close monitoring in clinical practice,” Professor Mishra said.
This study was published in the American Journal of Obstetrics and Gynecology.
Early menopause predictor of heart disease
Dongshan Zhu et al. Vasomotor Menopausal Symptoms and Risk of Cardiovascular Disease: A pooled analysis of six prospective studies, American Journal of Obstetrics and Gynecology (2020). DOI: 10.1016/j.ajog.2020.06.039
Hot flushes and night sweats linked to 70% increase in cardiovascular disease (2020, July 2)
retrieved 2 July 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022